Signup Crypto ETF Stocks News

Insight Investments Launches Insight Capital Finance to Provide Equipment Leasing Solutions for the Fitness Industry

COSTA Mesa, Calif., March 10, 2025 ( GLOBE NEWSWIRE ) -- Insight Investments, LLC today announced that it has launched Insight Capital Finance ( ICF ) , a new business unit dedicated to providing innovative leasing solutions to the fitness, healthcare and wellness markets.

Source: www.benzinga.com
March 10, 2025 | 13:00:00
Category: News

Graphitic Energy Commissions Pilot Plant to Produce Low-Cost Clean Hydrogen and Graphite

SAN ANTONIO, March 10, 2025 ( GLOBE NEWSWIRE ) -- Graphitic Energy, formerly known as C-Zero, has commissioned its pilot plant at the Southwest Research Institute ( SWRI ) in San Antonio, TX. This state-of-the-art facility is the company's first at-scale demonstration of its novel form of ...

Source: www.benzinga.com
March 10, 2025 | 13:00:00
Category: News

Ride in Style with JAKKS Pacific's New Roxy Dolls - Jakks Pacific ( NASDAQ:JAKK )

SANTA MONICA, Calif., March 10, 2025 ( GLOBE NEWSWIRE ) -- JAKKS Pacific JAKK is thrilled to introduce Roxy Dolls, an all-new fashion and action sports-inspired doll line launching exclusively at Target in June 2025. Get ready to roll, ride, and shred in style!

Source: www.benzinga.com
March 10, 2025 | 13:00:00
Category: News

GoPro's 'Grom Quest' Talent Search Program Brings Five New Stars into the GoPro Athlete Family - GoPro ( NASDAQ:GPRO )

SAN MATEO, Calif., March 10, 2025 /PRNewswire/ -- Today, GoPro GPRO announced the addition of five young athletes to its team of elite professional athletes through Grom Quest, GoPro's ongoing video-submission-based talent search program.

Source: www.benzinga.com
March 10, 2025 | 13:00:00
Category: News

Aware Deepens Executive Bench with Appointment of Brian Krause as Chief Revenue Officer - Aware ( NASDAQ:AWRE )

BURLINGTON, Mass., March 10, 2025 ( GLOBE NEWSWIRE ) -- Aware, Inc. AWRE, a leading global authentication company, today announces Brian Krause as its new Chief Revenue Officer. Brian is an accomplished go-to market leader with more than 10 years of experience in the biometric and digital ...

Source: www.benzinga.com
March 10, 2025 | 13:01:00
Category: News

Dolby and General Motors Bring Dolby Atmos to Cadillac's Entire 2026 EV Lineup - General Motors ( NYSE:GM ) , Dolby Laboratories ( NYSE:DLB )

SAN FRANCISCO and DETROIT, March 10, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. DLB, a leader in immersive entertainment experiences, and General Motors GM today announced that Dolby Atmos will be supported as an available feature across Cadillac's entire 2026 electric vehicle lineup.

Source: www.benzinga.com
March 10, 2025 | 13:01:00
Category: News

Telos Corporation Announces Fourth Quarter and Full Year 2024 Earnings

ASHBURN, Va., March 10, 2025 ( GLOBE NEWSWIRE ) -- Telos Corporation ( NASDAQ: TLS ) , a leading provider of cyber, cloud and enterprise security solutions for the world's most security-conscious organizations, has posted its 2024 fourth quarter and full year financial results on its investor ...

Source: www.globenewswire.com
March 10, 2025 | 13:02:00
Category: News

Amazon Music, DistroKid Face Major Lawsuit for Unpaid Royalties, Shadowbanning

NEW YORK, March 10, 2025 ( GLOBE NEWSWIRE ) -- Marc Mysterio is an award-winning musician and multi-faceted celebrity who was tapped by IBA Boxing to compete for its vacant championship vs.

Source: www.benzinga.com
March 10, 2025 | 13:02:00
Category: News

Raoul Pal Sees Bitcoin, Solana In 'Healing Stage', Predicts Market Recovery In Q2

Raoul Pal urges patience and strategic portfolio management to navigate the current correction. He expects crypto markets to recover in mid-March, with the second phase of the Banana Zone kicking in from April through June. Every week, our Whisper Index uncovers five overlooked stocks with big ...

Source: www.benzinga.com
March 10, 2025 | 13:05:15
Category: News

Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity - Beam Therapeutics ( NASDAQ:BEAM )

BEAM-302 showed durable, dose-dependent correction of AATD mutation in 9 patients with effects seen as early as Day 7. Beam plans further dose escalation and will report new trial data in H2 2025, while also enrolling patients with liver diseases.

Source: www.benzinga.com
March 10, 2025 | 13:07:08
Category: News

© Natavest 2025 - 2026